THIMPU, Bhutan, April 12: When plotted on a graph, the curve of Bhutan’s COVID-19 vaccination drive shoots upwards from the very first day, crossing Israel, United States, Bahrain and other countries known for vaccinating people rapidly.
NEW DELHI, April 11: New COVID-19 cases in India surged to a record of 152,879 on Sunday as the country battled a second wave of infections by pushing for faster vaccinations, with some states considering tougher restrictions to slow the spread of the virus.
NEW DELHI, Mar 13: Leaders of the United States, India, Australia and Japan agreed to pool financing, manufacturing and distribution capacity to send 1 billion coronavirus vaccines across Asia by the end of 2022, India’s foreign secretary said on Friday.
LONDON, Feb 3: The UK variant of the coronavirus has developed a new, concerning mutation in a small number of cases, which scientists said makes it similar to the South African and Brazilian variants and could reduce the efficacy of vaccines.
USA, Jan 3: The U.S. Centers for Disease Control and Prevention said it had administered 4,225,756 first doses of COVID-19 vaccines in the country as of Saturday morning and distributed 13,071,925 doses.
NEW DELHI, Jan 1: India’s drug regulator is set to approve on Friday a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, three sources with knowledge of the matter said.
NEWARK, Del, Dec 22: President-elect Joe Biden on Monday received his first dose of the coronavirus vaccine on live television as part of a growing effort to convince the American public the inoculations are safe.
PUNE, India/NEW DELHI, Dec 11: India, the world’s biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
FRANKFURT, Nov 22: Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).
LONDON, Oct 26: Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca Plc, show it produces a robust immune response in elderly people, the group at highest risk, the Financial Times reported on Monday.
TORONTO/CHICAGO, Sept 1: High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
COVID-19 pandemic has upended every aspect of lives around the world. Many people in the world including scientists and public health experts strongly believe that a vaccine is the only solution to combat the COVID-19 pandemic. Therefore, scientists and vaccine companies are working tirelessly to bring a safe and effective vaccine in the market. However, no matter how effective the vaccine will be, it will not solve this looming crisis until we eliminate deeply rooted mistrust against vaccines in general and burgeoning hesitancy toward the COVID-19 vaccine in specific.
WASHINGTON DC, July 15: The first COVID-19 vaccine tested in the U.S. revved up people’s immune systems just the way scientists had hoped, researchers reported Tuesday -- as the shots are poised to begin key final testing.
LONDON, July 12: The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
GENEVA, July 5: The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.
Top health officials say the end of this year would be a best case scenario. But scientists have never created a vaccine so quickly, and there’s no guarantee any under development will ultimately work.
WASHINGTON, May 4: Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope — maybe unrealistic — that an end to the pandemic may arrive sooner than anticipated.
BEIJING – The COVID-19 coronavirus poses a threat on a scale not seen since the so-called Spanish flu killed more than 50 million people in 1918-19. To confront the pandemic, many governments have imposed stay-at-home orders and even strict lockdowns, bringing the global economy nearly to a standstill. But the real solution to this crisis is not containment. It is innovation.
With now almost four months, the corona pandemic has resulted in over 100 thousand deaths. The modeling based on a number of tests and recovery data to date indicates some positive trend of recovery but it has not been very effective. The world focused on isolation measures, developing drugs and vaccines but various other options. Let me talk about those options. Vaccination is an ultimate cure as it helps the body to make an antibody to fight virus attacks. Scientists were able to quickly sequence the genetic materials of COVID-19 as early as in January and manipulate its gene sequence to develop a vaccine. A vaccine developed earlier for corona epidemics—SARS in 2002-04 and Mers in 2012—was never used as the virus was contained. These vaccines are now being trialed against COVID-19 by Novavax company and ready for human trials this spring. A biotech firm Moderna also claims that their vaccine will go for clinical trial soon in Australia. China is also on the race to try its own vaccine for clinical trials. A vaccine needs testing in animals first and then in humans in three-phase trials for approval. Thus it could cost several hundred million dollars.
The world is in a moment of absolute silence and mourning since the outbreak of COVID-19. Unexpected morbidity and mortality have challenged the world’s preparedness for disaster. Myriads of questions have evolved in each individual’s brain. It has become a challenge for humankind even in the modern era of science and technology. The pandemic outbreak has traumatized the world in such a way that it will take a long duration for its recovery.
SEOUL/BEIJING, Feb 25: South Korea aims to test more than 200,000 members of a church at the center of a surge in coronavirus cases while the United States pledged $2.5 billion to fight the disease, as it spreads rapidly beyond China’s borders to Europe and the Middle East.
LONDON, June 19: Trust in vaccines - one of the world’s most effective and widely-used medical products - is highest in poorer countries but weaker in wealthier ones where scepticism has allowed outbreaks of diseases such as measles to persist, a global study found on Wednesday.
New York eliminated the religious exemption to vaccine requirements for schoolchildren Thursday, as the nation’s worst measles outbreak in decades prompts states to reconsider giving parents ways to opt out of immunization rules.
ALBANY, June 14: New York eliminated the religious exemption to vaccine requirements for schoolchildren Thursday, as the nation’s worst measles outbreak in decades prompts states to reconsider giving parents ways to opt out of immunization rules.
ADEN, April 9: In the summer of 2017, a plane chartered by the United Nations idled on the tarmac at an airport in the Horn of Africa as officials waited for final clearance to deliver half a million doses of cholera vaccine to Yemen. Amid the country’s ruinous war, the disease was spiraling out of control, with thousands of new cases reported each day.
The World Health Organisation has been authorised to use an experimental vaccine to combat an outbreak of Ebola in the Democratic Republic of the Congo, where at least 19 people have been killed by the virus.
NAIROBI, Kenya, June 2: Fifteen young children have died in a botched measles vaccination campaign that saw people as young as 12 years old administering the vaccines, South Sudan's government announced Friday.
JOHANNESBURG, April 24: Three African countries have been chosen to test the world's first malaria vaccine, the World Health Organization announced Monday. Ghana, Kenya and Malawi will begin piloting the injectable vaccine next year with hundreds of thousands of young children, who have been at highest risk of death.
KATHMANDU, June 30:Child Health Division (CHD) under the Department of Health Services (DoHS) said that it has immunized over 3.2 million children under the age of 15 with Japanese encephalitis vaccine.